Dual-antigen targeted iPSC-derived chimeric antigen receptor-T cell therapy for refractory lymphomaSakiko Harada, Norio Komatsu, Manami Ohtaka et al.|Molecular Therapy|2021Cited by 48
Sustainable Tumor-Suppressive Effect of iPSC-Derived Rejuvenated T Cells Targeting Cervical CancersTadahiro Honda, Norio Komatsu, Miki Ando et al.|Molecular Therapy|2020Cited by 31
iPSC-derived hypoimmunogenic tissue resident memory T cells mediate robust anti-tumor activity against cervical cancerYoshiki Furukawa, Miki Ando, Midori Ishii et al.|Cell Reports Medicine|2023Cited by 25
iPSC-Derived Neoantigen-Specific CTL Therapy for Ewing SarcomaMidori Ishii, Miki Ando, Jun Ando et al.|Cancer Immunology Research|2021Cited by 19